Contact this trialFirst, we need to learn more about you.
SHP2 Inhibitor
BBP-398 + Nivolumab for Lung Cancer
Recruiting1 awardPhase 1
Charleston, South Carolina
This trial tests BBP-398 and nivolumab in patients with advanced lung cancer who have a specific genetic mutation and haven't responded to other treatments. BBP-398 blocks a protein that helps cancer grow, while nivolumab boosts the immune system to fight the cancer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service